PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 142 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2018. The put-call ratio across all filers is 1.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $826,000 | -65.0% | 64,993 | +6.7% | 0.05% | -66.7% |
Q1 2019 | $2,362,000 | +101.9% | 60,893 | +5.9% | 0.14% | +88.0% |
Q4 2018 | $1,170,000 | -19.5% | 57,493 | +133.8% | 0.08% | +27.1% |
Q2 2018 | $1,454,000 | -48.4% | 24,593 | -40.6% | 0.06% | -47.8% |
Q1 2018 | $2,816,000 | -15.2% | 41,393 | +23.2% | 0.11% | -23.1% |
Q4 2017 | $3,320,000 | +116.0% | 33,590 | +90.9% | 0.15% | +81.5% |
Q2 2017 | $1,537,000 | +97.3% | 17,594 | -30.7% | 0.08% | +76.1% |
Q4 2016 | $779,000 | -10.6% | 25,400 | +95.4% | 0.05% | -83.7% |
Q3 2016 | $871,000 | -25.8% | 13,000 | +14.6% | 0.28% | +354.8% |
Q4 2013 | $1,174,000 | -18.6% | 11,340 | -57.8% | 0.06% | -21.5% |
Q3 2013 | $1,442,000 | +61.1% | 26,880 | +33.3% | 0.08% | +172.4% |
Q2 2013 | $895,000 | – | 20,172 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
TOBAM | 318,384 | $23,994,000 | 0.94% |
Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |